STAT – The FDA approved for the first time a drug meant to mitigate the symptoms of opioid withdrawal — rather than an underlying dependency — giving American physicians a new tool to help patients begin treatment.
Food and Drug Administration – The FDA approved Gilenya to treat relapsing multiple sclerosis in children and adolescents age 10 years and older. This is the first FDA approval of a drug to treat MS in pediatric patients.
The New York Times – The clinics remove fat from patients’ bellies and inject an extract of it into various parts of the body, on the theory that the extract contains stem cells that can provide replacement cells.
TechCrunch – The cause of the fatal crash of an Uber self-driving car appears to have been at the software level, specifically a function that determines which objects to ignore and which to attend to.